ABSTRACT
A probe based on 2-(2'-hydroxyphenyl) benzothiazole (HBT) has been synthesized and used for the ratiometric detection of hydrazine. The probe is designed in such a way that the excited state intramolecular proton transfer (ESIPT) of the HBT moiety gets blocked. The chemodosimetric approach of hydrazine to the probe results in the recovery of the ESIPT by removal of a free HBT moiety through subsequent substitution, cyclization, and elimination processes. The probe is successfully demonstrated to enable the detection of hydrazine in live cells.
Subject(s)
Fluorescent Dyes/chemistry , Hydrazines/chemistry , Benzothiazoles/chemical synthesis , Benzothiazoles/chemistry , Cyclization , Molecular Imaging , Molecular Structure , Phenols/chemical synthesis , Phenols/chemistry , Protons , Spectrometry, FluorescenceABSTRACT
A sensitive, accurate and highly stereoselective assay for the simultaneous determination of venlafaxine (VEN) and its equipotent metabolite, O-desmethyl venlafaxine (ODV), in human plasma was developed and validated. Analytes were simultaneously extracted from plasma using solid-phase extraction and detected by tandem mass spectrometry in positive ion mode with a turbo ion spray interface. Deuterium-labeled VEN and ODV were used as internal standards. Chromatographic separation was performed on a Chiral AGP column, using a time programmed gradient flow with a total run time of 16 min. The method has a lower limit of quantitation of 0.60 ng/mL. The assay was linear over a range 0.60-300.00 ng/mL for both the enantiomers of VEN and ODV, respectively, with coefficient of correlation > 0.99. The extraction recoveries were >77.0% on an average for all the four analytes. The analytes were found stable in plasma through three freeze (-15 °C) and thaw cycles and under storage at room temperature for 8 h, and also in mobile phase at 10 °C for 54 h. The method has shown good reproducibility, with intra- and inter-day variation coefficients < 9%, for all the analytes, and has proved to be very reliable for analysis of VEN and its metabolite in clinical study samples.
Subject(s)
Chromatography, High Pressure Liquid/methods , Cyclohexanols/blood , Tandem Mass Spectrometry/methods , Acetates/chemistry , Cyclohexanols/chemistry , Cyclohexanols/pharmacokinetics , Desvenlafaxine Succinate , Drug Stability , Humans , Hydrogen-Ion Concentration , Least-Squares Analysis , Male , Reproducibility of Results , Sensitivity and Specificity , Spectrometry, Mass, Electrospray Ionization , Stereoisomerism , Temperature , Venlafaxine HydrochlorideABSTRACT
A thiophene-coumarin hybrid molecule, (6E)-6-((thiophen-2-yl)methyleneamino)-2H-chromen-2-one (TMC) has been prepared and its single crystal X-ray structure is reported. TMC can selectively detect Cr(3+) in presence of other common cations. Both TMC and its Cr(3+) complex are well characterized by different spectroscopic techniques like (1)H NMR, QTOF-MS ES(+), FTIR and elemental analysis as well. TMC exhibits fluorescence enhancement upon binding Cr(3+) in CH(3)CN-HEPES buffer (0.02 M, pH 7.4) (4:6, v/v) medium. Detection limit of the method is 1 × 10(-6)M. Binding constant is estimated with the Benesi-Hildebrand method and the value 8 × 10(4) indicates a fairly strong interaction between TMC and Cr(3+). Speciation studies have been performed in a fast and environment friendly way using least sample volume, less hazardous chemicals and solvents. Cr(3+) assisted restricted rotation around the imine bond and inhibited photo-induced electron transfer from the N,S-donor sites to the coumarin unit are responsible for fluorescence enhancement. TMC is capable to detect intracellular Cr(3+) in living cells.
